Doxorubicin: all 842 studies that test it

Page 3 of 9. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II TrialCompletedNCT00911183Phase 2Results posted
• Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00903630Phase 1/2Results posted
• Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast CancerCompletedNCT00895414Not applicableResults posted
• Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia SalvageCompletedNCT00890656Phase 2Results posted
• Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT00882206Phase 2Results posted
• A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue SarcomasCompletedNCT00878800Phase 1/2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00878254Phase 2Results posted
• Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic LymphomaCompletedNCT00866749Phase 2Results posted
• Trimodal Lung-Sparing Treatment of Pleural MesotheliomaTerminatedNCT00859495Phase 2Results posted
• Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
• Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple MyelomaTerminatedNCT00849251Phase 1/2Results posted
• Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid MalignanciesTerminatedNCT00837200Phase 2Results posted
• Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaTerminatedNCT00808899Phase 2Results posted
• Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)TerminatedNCT00779285Phase 4Results posted
• S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaCompletedNCT00770224Phase 2Results posted
• Phase II Study of Doxorubicin and Avastin® in Sarcoma.TerminatedNCT00755261Phase 2Results posted
• Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)CompletedNCT00750815Phase 1/2Results posted
• A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)CompletedNCT00727961Phase 4Results posted
• Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple MyelomaCompletedNCT00724568Phase 1/2Results posted
• Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or TopotecanTerminatedNCT00720096Not applicableResults posted
• Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular LymphomaCompletedNCT00715208Phase 2Results posted
• Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast CancerCompletedNCT00712881Phase 2Results posted
• A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersCompletedNCT00698451Phase 2Results posted
• A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)CompletedNCT00687440Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaCompletedNCT00671658Phase 2Results posted
• Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell LymphomaCompletedNCT00670358Phase 1/2Results posted
• Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/LymphomaCompletedNCT00669877Phase 2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary AdenocarcinomaTerminatedNCT00653328Phase 2Results posted
• Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerTerminatedNCT00636441Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• A Phase I/II Trial of VR-CHOP in Lymphoma PatientsCompletedNCT00634179Phase 1/2Results posted
• Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaCompletedNCT00630409Phase 2Results posted
• Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)CompletedNCT00617591Phase 2Results posted
• Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedNCT00609765Phase 2Results posted
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerCompletedNCT00608972Phase 2Results posted
• Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)TerminatedNCT00604968Phase 4Results posted
• Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed OsteosarcomaCompletedNCT00586846Phase 2Results posted
• Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and NeckCompletedNCT00581360Phase 2Results posted
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsCompletedNCT00577993Phase 3Results posted
• Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins LymphomaCompletedNCT00577629Phase 2Results posted
• Trial for Locally Advanced Breast Cancer Using Vorinostat Plus ChemotherapyCompletedNCT00574587Phase 1/2Results posted
• Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast CancerTerminatedNCT00574236Phase 2Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00558519Phase 2Results posted
• Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)CompletedNCT00550771Phase 2Results posted
• Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00549848Phase 3Results posted
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast CancerCompletedNCT00546156Phase 2Results posted
• Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone SarcomaTerminatedNCT00544778Phase 2Results posted
• Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast CancerCompletedNCT00544167Not applicableResults posted
• Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast CancerTerminatedNCT00542191Phase 2Results posted
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00524459Phase 2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerCompletedNCT00509665Phase 2Results posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With NeuroblastomaCompletedNCT00499616Phase 3Results posted
• NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast CancerCompletedNCT00499122Phase 2Results posted
• Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)CompletedNCT00499083Phase 2Results posted
• Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) PatientsCompletedNCT00494780Phase 2Results posted
• Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung CarcinomaCompletedNCT00483509Phase 2Results posted
• Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast CancerCompletedNCT00482391Phase 2Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• ALL Adult Consortium Trial: Adult ALL TrialCompletedNCT00476190Phase 2Results posted
• Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerCompletedNCT00470301Phase 1/2Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple MyelomaCompletedNCT00458705Phase 2Results posted
• Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate CancerCompletedNCT00456989Phase 1/2Results posted
• R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
• Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast CancerCompletedNCT00442260Phase 1/2Results posted
• ABT-751 With Chemotherapy for Relapsed Pediatric ALLTerminatedNCT00439296Phase 1/2Results posted
• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryCompletedNCT00436566Phase 2Results posted
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic CancerTerminatedNCT00426127Phase 2Results posted
• Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryCompletedNCT00407888Phase 2Results posted
• Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerCompletedNCT00404066Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' TumorCompletedNCT00379340Phase 3Results posted
• Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple MyelomaTerminatedNCT00366106Phase 2Results posted
• Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerCompletedNCT00365417Phase 2Results posted
• Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast CancerCompletedNCT00365365Phase 2Results posted
• High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaCompletedNCT00354744Phase 3Results posted
• Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' TumorCompletedNCT00352534Phase 3Results posted
• Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin LymphomaCompletedNCT00352027Phase 2Results posted
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaCompletedNCT00346164Phase 3Results posted
• Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsCompletedNCT00335556Phase 2Results posted
• Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerCompletedNCT00331552Phase 1/2Results posted
• Docetaxel in Breast CancerCompletedNCT00312208Phase 3Results posted
• Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)CompletedNCT00307294Phase 2Results posted
• Study of NGR-hTNF in Combination With Doxorubicin in Solid TumorsCompletedNCT00305084Phase 1Results posted
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerCompletedNCT00303108Phase 2Results posted
• Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's LymphomaCompletedNCT00302003Phase 3Results posted
• Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell LymphomaCompletedNCT00290433Phase 2Results posted
• Adjuvant Chemotherapy for High Risk Uterine LeiomyosarcomaCompletedNCT00282087Phase 2Results posted
• Partial Breast Irradiation With ChemotherapyCompletedNCT00278109Phase 1/2Results posted
• The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)CompletedNCT00266799Phase 3Results posted
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerCompletedNCT00258960Phase 2Results posted
• Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast CancerCompletedNCT00256243Phase 2Results posted
• Neoadjuvant Treatment of Breast CancerCompletedNCT00254592Phase 2Results posted
• A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of LifeCompletedNCT00222105Phase 2Results posted
• Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedNCT00215943Phase 3Results posted
• A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell LymphomaCompletedNCT00211185Phase 2Results posted
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsCompletedNCT00206518Phase 2Results posted

← Doxorubicin overview